INNO-LIA® HCV Score
Optimal coverage of immunodominant HCV epitopes using unique and specific antigens
Line immunoassay for the detection of antibodies to human hepatitis C virus in human serum and plasma. It is intended for use as a supplementary test on human serum or plasma specimens found to be reactive in an anti-HCV screening procedure.
The INNO-LIA HCV Score assay utilizes well-defined antigens derived from HCV immunodominant proteins from the core region, the E2 hypervariable region (HVR), the NS3 helicase region and the NS4A, NS4B and NS5A regions. The antigens used are either recombinant proteins or synthetic peptides, highly purified, and fixed on a nylon membrane.
Product number 80538
-
Documentation
Browse regulatory documents for this product
Create a (free!) eServices account and start browsing all regulatory documentation right away.
Multimedia
Watch product videos
Get a (free!) eServices account and benefit from full access to all our online resources.
Other documents
FileFAQ - INNO-LIA HCV Score (pdf, 251.19 kb)FileList_of_recommended_reading_publications_for_INNO-LIA_HCV_Score.pdf (pdf, 155.68 kb)Get access to this section and more
Create a free eServices account now and instantly access multiple digital resources:
- Regulatory product documentation
- Selected scientific posters
- Product leaflets
- How-to videos and more…
-
FAQ
How does the coronavirus disease Covid-19 impact Fujirebio's operations?
Please see the following statement on the impact of coronavirus disease Covid-19 on the operations of Fujirebio Europe (updated January 19, 2021).
-
Related products
-
Product inquiry
